September 26, 2019
Kymera Therapeutics to Relocate from Cambridge to Watertown Biotech Cluster
Arsenal Yards’ Phase One Biotech Lab Space Now 100% Leased
WATERTOWN, September 26, 2019 – Boylston Properties, a Boston-based real estate developer of distinctive places, today announced that Kymera Therapeutics has signed a lease for approximately 34,500 square feet at Arsenal Yards‘ new state-of-the-art life science lab space. With the Charles River and Arsenal Park on its south side and energized shops and restaurants on its north side, the life science lab space is set within an original 1800s Arsenal historic building, offering a number of amenities and a private shuttle to the Harvard Square red line T stop.
Life science companies are flocking to Watertown to secure space in the town’s booming biotech scene. Kymera Therapeutics continues this trend, joining SQZ Biotech in moving to Arsenal Yards’ life science lab space. The new development is located across the street from LINX, 185,000 square feet of currently fully leased lab space, also developed by Boylston Properties.
“Given the state-of-the-art amenities and proximity to life science’s biggest names and talent, Watertown is now a first choice for life science companies,” said Bill McQuillan, Principal of Boylston Properties. “We’re proud to welcome Kymera Therapeutics to the Watertown life science cluster and look forward to supporting their continued growth. We are thankful to have worked alongside the great commercial real estate professionals at Cushman & Wakefield and Newmark to be able to welcome another cutting-edge life science company to Arsenal Yards.”
Read the full press release
Categories: OfficeBack to News & Press >